Notably, most of the tumor samples showed extremely low expression of miR-892b and ENCORI pancancer co-expression analysis predicted that there was no significant correlation between the expression of SNHG16 and miR-892b, and between PPAPDC1A and miR-892b in BC patients. Here, SNHG16 is linked to breast cancer.